In order to deliver glial cell line-derived neurotrophic factor (GDNF) into the brain, we have established a cell line that produces GDNF in a continuous fashion by genetic engineering. These cells were encapsulated and grafted into parkinsonian model rats that had received unilateral intrastriatal injection of 6-hydroxydopamine 2 weeks earlier. Neurochemical analysis showed that GDNF has been produced from the capsule for 6 months after grafting and histological analysis revealed good survival of GDNF-producing cells in the capsule 6 months after grafting. The density of nigrostriatal dopaminergic fibers in the striatum as well as the number of dopaminergic cell bodies in the substantia nigra recovered significantly after GDNF-producing cell grafting. These results suggest the possible application of GDNF-producing cell grafting for the treatment of Parkinson's disease.
INTRODUCTION
the striatum of parkinsonian model rats in order to evaluate the efficacy of GDNF-producing cells in regenerating the host nigrostriatal dopaminergic system. The recent development of molecular biology techniques has enabled various types of cell lines to be generated. When cell lines that secrete neurotransmitters or MATERIALS AND METHODS neurotrophic factors are used as donor cells for neural
In all experiments, adult Sprague-Dawley rats were transplantation, there are theoretical advantages such used according to approved guidelines of the instituas unlimited availability and ease of genetic handling. tional animal case and use committee of Okayama Uni-However, there are issues of immunological reaction versity. Animals had free access to food and water, and and tumorigenesis. To overcome these problems, the were maintained in a 12:12 h light/dark cycle. The anitechnique to envelope these cells into polymer capsules, mals were deeply anesthetized with Nembutal and which consist of a semipermeable membrane, has been placed in a stereotaxic frame. The skull was exposed and developed (1,10). Because the capsule is semipermeable, burr holes were made using a high-speed dental drill. oxygen and nutrition can be provided into the capsule All animals were administered 6-hydroxydopamine (6and neurotransmitters or neurotrophic factors can be se-OHDA) in the left striatum (1.0 mm anterior to bregma, creted from the capsule, but antibodies or immunocytes 3.0 mm lateral, 6.0 mm ventral to the dural surface). cannot penetrate the capsule. Thus, the inside of the cap-Two weeks after 6-OHDA was administered, rats resule is immunologically privileged. In addition, the rigid ceived an encapsulated cell grafting into the left striatum nature of the capsule is able to regulate tumor formation as described below. of the cells.
Baby hamster kidney (BHK) cells were transfected Glial cell line-derived neurotrophic factor (GDNF) is with a vector containing the cDNA for human GDNF one of the most potent neurotrophic factors for dopaminusing the cationic liposome method similar to the way ergic neurons (12) . In the present study, we established we established nerve growth factor (NGF)-producing a cell line that produces GDNF by genetic manipulation cells in previous studies (6) (7) (8) . Transfected BHK-GDNF or nontransfected BHK control cells were maintained in and these cells were encapsulated and transplanted into 398 DATE ET AL. vitro and harvested prior to encapsulation, and hollow analysis system as described previously (2-5). The total number of TH-ir neurons in the substantia nigra pars fibers of polysulfone were prepared as previously described (6) (7) (8) (9) . Cultured cells were prepared as a single-compacta was counted on both sides. The degree of dopamine neuron depletion was determined by the loss of cell suspension and infused into individual capsules, then the access port was sealed with light-cured plastic.
TH-ir substantia nigra pars compacta neurons on the lesioned side with respect to the control side of the brain. Encapsulated cells were grafted into the left striatum at the same location as 6-OHDA was injected 2 weeks ear-RESULTS lier (Fig. 1) .
Rotational tests were carried out in an automated ro-The cell-loaded devices were easily retrieved with little host tissue adhering to the capsule wall. At 1, 3, and tometer system with rats placed in rotometer bowls and secured with a thoracic harness to facilitate counting. 6 months following transplantation, all capsules were removed intact, no evidence having been found that any Once the rats were acclimated for 10 min, apomorphine was administered. The number of 360°turns to the left capsule had broken either in situ or during the retrieval procedure, and morphological analysis showed that all or right was recorded for a period of 1 h. Net contralateral turns to the lesion were calculated by subtracting capsules contained a large number of viable BHK-GDNF cells (Fig. 2) . The long-term viability of the the turns to the left from the turns to the right.
After completion of rotational behavior analysis, ani-BHK-GDNF cells was consistent with continuous secretion of GDNF from the retrieved capsules, although the mals were deeply anesthetized with Nembutal and sacrificed by intracardiac perfusion with 4% paraformalde-level of secretion decreased slightly compared with the pregrafting value ( Fig. 3 ). hyde in 0.1 M phosphate buffer. Brains were removed and postfixed for 24 h in the perfusion fixative at 4°C.
Animals receiving a control capsule showed a continuous increase of apomorphine-induced rotation until 6 The tissue was frozen on dry ice and 40-µm sections were cut using a sliding microtome. Sections were pro-months after grafting. However, animals that received BHK-GDNF capsule showed decreased rotation at all cessed for visualization of tyrosine hydroxylase (TH)immunoreactive (ir) profiles in the striatum using avi-periods investigated until 6 months after grafting. Immunocytochemical studies supported the functional efficacy din-biotin procedure and the density of TH-ir fibers was subsequently determined using a computerized image of encapsulated BHK-GDNF cell grafting. In the control group striatal injection of 6-OHDA resulted in a marked DISCUSSION disappearance of TH-ir fibers in the striatum. In rats that
In the present study, we have shown that intrastriatal received an implantation of encapsulated BHK-GDNF grafting of GDNF-producing cells could induce recovcells, the density of TH-ir fibers was significantly ery of nigrostriatal dopaminergic system in rats, and this greater than that in the control group (Fig. 4) . Similarly, effect persisted for 6 months after grafting. administration and demonstrated that the number of do-demonstrated the long-term efficacy of this grafting procedure. Because Parkinson's disease is a progressive paminergic neurons in the substantia nigra and the dopaminergic fiber density in the striatum increased by the neurodegenerative disorder, longer term (year level) evaluation including the durability of the capsule is de-GDNF treatment. Multiple injection of GDNF was performed in both of these studies; although multiple injec-sired.
Due to the development of molecular biology tech-tion of neurotrophic factors can be performed in experimental animals, we assumed that the alternative method niques, several types of neurotrophic factor-producing cells can be created. Encapsulation and grafting of these should be addressed when considering clinical application. One of the merits of encapsulated neurotrophic fac-cells are expected to be applied not only for Parkinson's disease but also for several neurological disorders such tor-producing cell grafting is that it can provide the factor continuously for a long period of time without as Huntington's disease, Alzheimer's disease, amyotrophic lateral sclerosis, cerebral ischemia, spinal cord in-repeating the procedure (1,9,10). Thus, we tried encapsulated GDNF-producing cell grafting in the present jury, etc., in the near future. In our laboratory, we have established nerve growth factor (NGF)-producing cells, study and could show the favorable results. Although GDNF production was continuously observed through-basic fibroblast growth factor (bFGF)-producing cells, and GDNF-producing cells, and studies are currently un-out the experiment, direct expression of GDNF gene was not examined in the present study. Further study is der way using these cell lines for the treatment of animal models of the above-mentioned neurological disorders. needed to show whether the capsule can block the host influence on the gene expression of the encapsulated ACKNOWLEDGMENTS: This work was supported in part by cells.
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